Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C.

Y-Y Zheng,L-F Wang,X-H Fan,C-H Wu,N Huo,H-Y Lu,X-Y Xu,L Wei
DOI: https://doi.org/10.1111/j.1365-2893.2012.01644.x
2013-01-01
Journal of Viral Hepatitis
Abstract:Suppressor of cytokine signalling 3 is thought to be associated with insulin resistance in patients with chronic hepatitis C. We evaluated the role of suppressor of cytokine signalling 3 polymorphisms in determining insulin resistance in patients with chronic hepatitis C. Two hundred and ninety untreated hepatitis C virus-infected patients without diabetes and cirrhosis were genotyped for the SNPs rs4969168, rs4969170 and rs12952093 of suppressor of cytokine signalling 3 using the TaqMan Genotyping Assay. We found that the rs4969170 AA genotype and rs4969170 A allele frequency were significantly more common in the insulin-resistant group than the non-insulin-resistant group (89.5% vs 76.1%, OR=2.693, 95% CI: 1.221-5.939, P=0.012 and 94.8% vs 88.0%, OR=2.463, 95% CI: 1.1515.271, P=0.017, respectively). Haplotype G-C was likely associated with non-insulin resistance (adjusted P=0.011). Multiple logistic regression analysis indicates that the independent risk factors for insulin resistance are the SNP rs4969170 AA genotype (OR=3.005, 95% CI: 1.1947.560, P=0.019), HCV genotype 1 (OR=2.524, 95% CI: 1.0995.794, P= 0.029) and BMI (OR=0.514, 95% CI: 0.2650.999, P=0.05).
What problem does this paper attempt to address?